20/20 Side Chat with Mark Wallace MD

The discussion includes a look at upper motor neuron presentations stemming from Multiple Sclerosis, post-stroke or spinal cord injuries, and lower motor neuron presentations, such as persistent muscle spasms localized to the cervical or lumbar region.

Featuring: Steven P. Stanos, DO, Medical Director of Swedish Health System Pain Medicine and Services in Seattle, Washington

Moderated by: PPM Co-Editors-at-Large Jeff Gudin, MD, and Jeffrey Fudin, PharmD, FCCP, FASHP

(September 2021, 16 minutes)

PPM Editor-at-Large Jeff Gudin, MD, interviews his long-term colleague, co-editor, and friend, Jeffrey Fudin, about what his recent diagnosis has taught him about opioids, patient care, and the field of clinical pharmacy as it stands in pain management. The duo discuss everything from Dr. Fudin’s early career in “hemonc” to how pharmacists are trained today, the pipeline analgesics and alternative therapies they are most excited about, the need for patient navigators in pain medicine, and what future clinicians need to know.

(30 minutes, June 30, 2021)

In PPM's new Case Chat series, neurologist Charles Argoff, MD, and anesthesiologist/pain fellow Ben Portal, MD, use a recent chronic headache case to discuss how treatment approaches have evolved, including primary care assessment tools and multitherapy use. Moderated by PPM Co-Editors-at-Large Jeff Gudin, MD, and Jeffrey Fudin, PharmD, FCCP, FASHP.

(May 2021, 22 minutes)

(November 2020)

A conversation on provider bias, a history of suboptimal care, and why telemedicine may be further hindering healthcare access for minority patients.

(September 2020)

A conversation with Nathaniel Katz, MD, of Analgesic Solutions, on clinical trial research and the future of pain therapeutics, including the use of patients as measurement instruments, and why we need to remember the history of opioid use and the purpose of rational management to make real progress.

(July 2020)

Clinical pharmacist and pain specialist Suzanne Amato Nesbit, PharmD, FCCP, BCPS, CPE, shares her take on the evolving state of pain medicine, including a look at the role of physicians and community pharmacists in opioid stabilization, how young trainees should incorporate addiction medicine into their studies, and how the COVID-19 pandemic is revealing clinical disparities in an already vulnerable patient population.

(May 2020)

President-Elect of the World Institute of Pain, Peter Staats, MD, MBA, shares his 20/20 vision on the evolution of the pain management field, from previously unimaginable advancements in neuromodulation, such as vagus nerve stimulation, to what future pain specialists need to know about their patients, collaboration, and money.

(April 2020)

Developer of the Opioid Risk Tool and past president of AAPM, Lynn Webster, MD, shares his 20/20 vision on the evolution of pain medicine, from the beginning of pain management as a specialty to a future where digital medicine and behavioral support may lead the way.

(February 2020)